Medicenna Therapeutics Corp. Key Management Personnel Compensation
Medicenna Therapeutics Corp. (MDNAF) reported Key Management Personnel Compensation of CAD 2.56 million for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensation · last filed 2023-06-27
| Period end | Key Management Personnel Compensation 12 month |
|---|---|
| 2023-03-31 | 2.56M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 2.73M CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 2.53M CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | 1.91M CAD 20-F · filed 2022-06-22 |